Interventional Radiology for Local Immunotherapy in Oncology.Human intratumoral immunotherapy (HIT-IT) is under rapid development, with promising preliminary results and high expectations for current phase III trials.  The technical considerations for HIT-IT affect the safety, efficacy, and further development of this treatment option.  The aim of this article is to share the technical insights of HIT-IT, with particular consideration for patient selection, lesion assessment, image guidance, and technical injection options.  In addition, the organization of a standard patient workflow is discussed, so as to optimize HIT-IT outcome and the patient experience.
HIT-IT
Interventional Radiology for Local Immunotherapy in Oncology.Human intratumoral immunotherapy (HIT-IT) is under rapid development, with promising preliminary results and high expectations for current phase III trials.  The technical considerations for HIT-IT affect the safety, efficacy, and further development of this treatment option.  The aim of this article is to share the technical insights of HIT-IT, with particular consideration for patient selection, lesion assessment, image guidance, and technical injection options.  In addition, the organization of a standard patient workflow is discussed, so as to optimize HIT-IT outcome and the patient experience.
HIT-IT
Interventional Radiology for Local Immunotherapy in Oncology.Human intratumoral immunotherapy (HIT-IT) is under rapid development, with promising preliminary results and high expectations for current phase III trials.  The technical considerations for HIT-IT affect the safety, efficacy, and further development of this treatment option.  The aim of this article is to share the technical insights of HIT-IT, with particular consideration for patient selection, lesion assessment, image guidance, and technical injection options.  In addition, the organization of a standard patient workflow is discussed, so as to optimize HIT-IT outcome and the patient experience.
HIT-IT
Interventional Radiology for Local Immunotherapy in Oncology.Human intratumoral immunotherapy (HIT-IT) is under rapid development, with promising preliminary results and high expectations for current phase III trials.  The technical considerations for HIT-IT affect the safety, efficacy, and further development of this treatment option.  The aim of this article is to share the technical insights of HIT-IT, with particular consideration for patient selection, lesion assessment, image guidance, and technical injection options.  In addition, the organization of a standard patient workflow is discussed, so as to optimize HIT-IT outcome and the patient experience.
HIT-IT
Interventional Radiology for Local Immunotherapy in Oncology.Human intratumoral immunotherapy (HIT-IT) is under rapid development, with promising preliminary results and high expectations for current phase III trials.  The technical considerations for HIT-IT affect the safety, efficacy, and further development of this treatment option.  The aim of this article is to share the technical insights of HIT-IT, with particular consideration for patient selection, lesion assessment, image guidance, and technical injection options.  In addition, the organization of a standard patient workflow is discussed, so as to optimize HIT-IT outcome and the patient experience.
HIT-IT